Bioengineering inquiry hears from industry advisors
20 January 2010 (updated on 22 April 2010)
The House of Commons Science and Technology Committee inquiry into bioengineering continues at 9.30am.
Witnesses
- Professor Lisa Jardine, Chair, Human Fertilisation and Embryology Authority
- Dr Paul Logan, Head of Policy, Hazardous Installations Directorate, Health and Safety Executive
- Professor Chris Pollock CBE, Honorary Professor, University of Aberystwyth
- Dr Martyn Ward, Head, Clinical Trials Unit, Medicines and Healthcare products Regulatory Agency
The inquiry is examining how the UK can maintain a globally competitive position in emerging and existing bioengineering research fields.
The inquiry will focus on three areas: research, translation and regulation. The inquiry will take synthetic biology, stem cells and genetic modification (GM) as areas within which to explore the issues of research, translation and regulation.